Skip to main content
EuBiologics Co., Ltd. logo

EuBiologics Co., Ltd. — Investor Relations & Filings

Ticker · 206650 ISIN · KR7206650004 KO Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2022-04-13 Director's Dealing
Country KR South Korea
Listing KO 206650

About EuBiologics Co., Ltd.

http://eubiologics.com/eng/

EuBiologics Co., Ltd. is a biopharmaceutical company focused on improving global public health through the development and supply of safe and effective vaccines. The company specializes in preventative vaccines against global pandemics and emerging infectious diseases, with a key product being its oral cholera vaccine. In addition to its vaccine pipeline, EuBiologics provides Contract Research and Manufacturing Organization (CRMO) services. These services cover the development and GMP-compliant production of mammalian cell and microbial-derived biopharmaceuticals, including protein-based therapeutics and antibodies. The company is committed to technological innovation and adhering to international standards to address global health challenges.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders (directors/executives) to disclose changes in their shareholdings. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in ownership by company directors and executives.
2022-04-13 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to contract terms, such as unit price and contract duration, for a supply agreement with UNICEF. Since this is a specific regulatory disclosure of a material contract event and does not fit into categories like Annual Reports, Earnings Releases, or M&A, it is classified as a Regulatory Filing (RNS).
2022-04-13 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from a Korean company (Eubiologics) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) with UNICEF. This type of filing is a standard regulatory announcement of a material business contract, which does not fit into specific categories like dividends, M&A, or earnings releases. Therefore, it falls under the 'Regulatory Filings' (RNS) category as a general corporate disclosure.
2022-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/KRX). It details changes in share ownership by a major shareholder (BioNote) in the issuing company (U-BioLogics). This type of filing is specifically categorized as 'Director's Dealing' (DIRS) in the provided schema, as it reports insider/major shareholder transactions.
2022-04-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from a General Meeting of Shareholders (정기주주총회결과). It details the voting outcomes for various agenda items such as financial statement approval, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the granting of stock options (주식매수선택권 부여에 관한 신고). This type of disclosure, which details the issuance of stock options to directors or employees, falls under the category of capital changes or share-related announcements. Given the specific nature of stock option grants, it is best classified as a share/capital change announcement.
2022-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.